Automating prostate radiotherapy treatment planning is dosimetrically complex, particularly for extreme hypofractionated regimens. In this study, we introduce Dose-PlanNet, a physics-guided 3D deep learning architecture designed to predict dose distributions. This model's performance was evaluated on a cohort of patients treated in a prospective trial where two different dose fractionation regimens were employed. Dose-PlanNet achieved comparable target coverage ($D_{95}$), though statistical analysis revealed a marginal reduction in target homogeneity ($p<0.001$) offset. However the model achieved statistically significant improvements in high-dose organ-at-risk sparing ($p<0.001$). When evaluated against strict Prospective Randomized protocol volumetric constraints, automated plans met prespecified clinical acceptance criteria in $11$ out of $14$ Moderate Hypofraction Arm plans and $9$ out of $12$ Stereotactic Body Radiation Therapy Arm plans. This pipeline demonstrates that physics-informed deep learning can accelerate radiotherapy workflows while safely maintaining the stringent dosimetric quality required for high-precision clinical deployment.
Christian Grashei, Fabian Gülhan, Maximilian Legnar +4cs.CV
Prostate cancer is among the most frequently diagnosed malignancies worldwide, and structured reporting of each biopsy core burdens pathologists. Existing tools frame this as classification, leaving pathologists to assemble coherent reports, while many slide-level vision-language models rely on English-centric encoders that transfer poorly to other clinical languages. We present a slide-level framework generating prostate biopsy reports that is language-independent by construction: tokenizer and model are trained from scratch, demonstrated here in German. To address paired-data scarcity, an automated pipeline uses a locally deployed large language model to split composite reports into core-specific image-text pairs, yielding 17,344 pairs from 2,402 historical cases without manual annotation. Evaluated for clinical attributes rather than linguistic similarity, the model achieves 96.2% F1 for malignancy detection and 65.2% for Gleason grading, competitive with an FDA-cleared classifier. Grading is further validated on three external cohorts with latent-space augmentation. Institutions can thus train native-language reporting models on their own archives.
Robert N. Spaans, Catherine Chia, Tongjie Wang +7eess.IV cs.CV
Biochemical recurrence (BCR), defined as any detectable prostate-specific antigen level after prostatectomy with confirmatory elevation, is widely used as a surrogate endpoint and typically assessed using clinical and pathological variables. Currently, no standardized benchmark exists for multimodal prognostic modeling in urological cancers, partly because curating heterogeneous multimodal data remains challenging. We developed the CHIMERA Challenge, a multimodal benchmark integrating preoperative mpMRI, post-prostatectomy histopathology, patient characteristics, and clinician-derived variables from 267 patients across two institutions. The dataset comprises 801 MRI sequences, 13 clinical variables per case, and 942 WSIs. Training (n=95), validation (n=23), and test (n=149) splits were established and hosted on the Grand Challenge platform. Baseline clinical and pathological characteristics did not differ significantly across splits. Models were evaluated on predicting time to BCR using the C-index. Post-challenge analyses tested how each model type performed when clinician-derived variables were withheld or randomized. Unimodal clinical models achieved the highest test C-index of 0.7402 but proved sensitive to the integrity of these variables, with performance collapsing toward chance (C approximately 0.50) when they were randomized. Multimodal models retained near-baseline performance when these variables were withheld (delta C at most 0.04), indicating their ability to recover prognostic signal directly from imaging data. CHIMERA is the first public, standardized multimodal benchmark for prostate cancer prognosis. Although models using only patient characteristics and clinician-derived variables yielded the highest leaderboard performance, multimodal models demonstrated greater robustness in clinically realistic scenarios where complete expert annotation is not guaranteed.
PSMA and FDG PET/CT visualise complementary biological information in prostate cancer. Combining both tracers could capture heterogeneous tumour phenotypes that may be missed by either alone, yet there is no consensus on effective deep learning architectures for fusing these modalities. We evaluated multimodal image-fusion strategies for automatic whole-body PET/CT lesion segmentation to estimate total tumour burden. Using the public DEEP-PSMA Challenge dataset, we trained tracer-specific 3D nnU-Net baselines and compared (i) early fusion with a single encoder and one decoder (OEOD) or two decoders (OETD), and (ii) intermediate fusion via a dual-encoder cross-attention U-Net (DECA-UNet). Tracer-specific baselines performed strongly (PSMA Dice = 0.93; FDG = 0.81). Fusion yielded mixed results: OEOD produced a combined Dice of 0.90 (on an easier, non-tracer-specific task), whilst the tracer-specific fusion models reached PSMA/FDG = 0.69/0.64 (OETD) and 0.76/0.57 (DECA-UNet). Whilst fusion often provided reasonable PSMA segmentation, FDG performance degraded and no strategy consistently exceeded the single-tracer baselines. Under the evaluated setting, tracer-specific models remain the stronger baseline; clinically useful gains from multimodal fusion will likely require architectures that better preserve tracer specific representations. Our code is available at: https://github.com/JackJ3636/DEEP_PSMA_code
Prostate cancer claims a life every 80 seconds. Early detection is needed to prevent disease progression, and both PSA density calculation and biopsy decisions rely on knowing the exact boundary of the gland. Conventional ultrasound at 6-12 MHz blurs this boundary, missing one in three high-risk cancers. Micro-ultrasound (29 MHz) improves resolution threefold but introduces dense acoustic speckle that obscures the outer wall; given the same image, two clinicians draw outlines differing by over 10% in area. Supervised methods are costly and generalise poorly across scanners. Can a foundation model segment the prostate with no training data? We present the first zero-shot pipeline for this modality: MedSAM, pre-trained on over 1.5 million medical images, localises the prostate; we then apply CLAHE to sharpen the outer wall, binary dilation to recover missed pixels, and Fourier smoothing (4 modes, s=1.05) to refine the boundary. MedSAM requires a spatial prompt, so we evaluate bounding-box and point-click strategies across 75 patients of the Micro-Ultrasound Prostate Segmentation dataset (2,621 slices). On the 20-patient held-out test set, the pipeline reduces mean boundary-distance error by 45% (Dice 0.749+/-0.043 to 0.865+/-0.029; HD95 217.2+/-36.9 to 120.1+/-26.1 px), reaching Dice 0.859 across the cohort. Its mean overlap shows no significant difference from the three non-expert rater groups (p>0.19), while segmenting 38-52% more consistently (lower inter-patient standard deviation). Point-click prompts fail regardless of placement (best Dice=0.350), because speckle gives no stable local contrast. Only an approximate bounding box is required, so any clinic can deploy it without data collection, annotation, or retraining.
Rashmi Bhaskara, Waleed M. Almutairi, Matthew Gopaulchan +5cs.CV physics.med-ph
Deep learning models that synthesize PET from CT or MRI can reduce patient dose and scanner demand, but are typically optimized with global losses such as L1 or mean squared error (MSE) that treat all voxels similarly. In whole-body PSMA-PET, tumor voxels occupy only a small fraction of the volume, yet carry the clinically relevant activity signal; as a result, models can achieve high structural similarity index measure (SSIM) and peak signal-to-noise ratio (PSNR) while still underestimating lesion activity or failing to preserve tumor-specific structure. Radiomics provides biologically meaningful descriptors of tumor intensity and texture, but direct radiomics conditioning is time-consuming because it requires feature extraction from delineated lesion regions. We propose LAFNO, a Lesion-Aware Adaptive Fourier Neural Operator for CT-to-PSMA-PET synthesis that replaces high-dimensional radiomics conditioning with two efficient CT-derived proxy channels. Motivated by radiomics analysis of PSMA-avid tumor core and peritumoral regions, LAFNO uses a contrast proxy for local density variation and a disorder proxy for local texture heterogeneity, both injected into the model bottleneck. LAFNO combines whole-volume reconstruction with lesion-level total lesion activity (TLA), tumor-core contrast, and peritumoral supervision. We evaluated LAFNO against four baseline architectures on the TCIA PSMA-PET-CT-Lesions dataset. LAFNO remained competitive on whole-volume image quality, achieving SSIM of 0.960 and 0.938 for 18F- and 68Ga-PSMA, respectively, while reducing per-patient TLA error to 48.3% and 64.0% for 18F- and 68Ga-PSMA, respectively, and achieving the highest tumor-core radiomics reproducibility across all feature classes for both tracers. Peritumoral reproducibility remained tracer-dependent, indicating that biological fidelity in synthetic PSMA-PET remains challenging.
In prostate cancer histopathology, the Gleason Score is determined by the most frequent (Primary) and second most frequent (Secondary) Gleason patterns within a whole-slide image. Although these slide-level labels are routinely available in clinical practice, instance-level Gleason annotations are rarely provided, making patch-level learning challenging. We propose a Multiple Instance Learning (MIL) framework that estimates instance-level Gleason patterns from slide-level Primary and Secondary labels. The proposed method formulates instance-level learning according to the clinical definition of the Gleason Score by aggregating instance predictions into class counts and explicitly modeling the Primary pattern, Secondary pattern, and their dominance. Experimental results demonstrate that the proposed formulation enables effective instance-level learning and outperforms existing MIL approaches on the SICAP-MIL dataset.
The allocation of visual attention by pathologists during cancer diagnosis is a highly selective process that critically shapes the information extracted from whole-slide images (WSIs). Human attention helps medical imaging tasks such as classification and segmentation, and becomes a strong semantic cue for identifying diagnostically informative regions for report generation. In this paper, we introduce human attention into the training of pathologist report generation models. To this end, we collected a multimodal human-attention dataset of 121 prostate WSIs annotated with pathologists' multi-scale viewport trajectories synchronized with the pathologists' verbal descriptions and cursor movements for five clinically relevant components (e.g., Gleason patterns). Using this dataset, we finetune two report generation models with an attention-alignment loss that regularizes the model attention over image patches to match the distribution of pathologist attention. We evaluate our approach on prostate cancer report generation and visual question answering using two models with different internal attention mechanisms (i.e., how image tokens are integrated into the language decoder). Experiments show average gains of 10.9% on NLP-based metrics and 19.3% in accuracy across five clinically relevant report components. Further, model attention maps extracted at inference time, with minimal computational overhead, align more closely with pathologist attention, providing stronger visual support for the generated reports by highlighting the regions that most influence the output.
Prostate cancer diagnosis with multiparametric MRI (mpMRI) is commonly based on PI-RADS assessment or binary classification, which suffer from subjectivity and fail to capture clinically relevant pathological heterogeneity. To address this limitation, we construct a Prostate Cancer Histopathology Spectrum Dataset (PCa-HSD) and formulate a clinically meaningful four-class classification task, addressing the underrepresentation of benign lesions that are easily confounded with prostate cancer in existing datasets. We propose Language-guided Segmentation-assisted Diagnostic Transformer model (LSDT), which leverages zero-shot segmentation to provide anatomical priors and performs effective multi-modal slice fusion for classification. Our proposed method consistently improves accuracy across backbones, achieving the best average accuracy of 0.633 and JointRecall of 0.768 in five-fold cross-validation on a cohort of 344 patients. These results demonstrate that integrating pathology supervision and anatomical priors significantly enhances fine-grained prostate MRI classification and provides a more clinically relevant paradigm for risk stratification. Code will be made publicly available in a future revision.
Hongye Zeng, Shreeram Athreya, Dingyuan Dai +4cs.CV
Active surveillance (AS) is the preferred strategy for favorable-risk prostate cancer, yet current protocols rely on scheduled repeat biopsies, most of which reveal no progression and are unnecessary. Existing risk-stratification tools operate on single time-point imaging or depend on explicit lesion segmentation, limiting their ability to capture longitudinal change and excluding patients without an MRI-visible lesion. In this study, we propose an end-to-end temporal and multimodal model for predicting pathological progression during AS without lesion segmentation. We encode each serial scan with a pretrained 3D MRI foundation model and introduce a temporal attention gate that recalibrates the multi-visit features to amplify focal imaging changes associated with progression. The gated imaging representation is then fused with clinical variables in a multimodal framework to estimate the probability of progression. Validated on a longitudinal AS cohort, our approach consistently outperforms competing baselines and performs comparably to the radiologist assessment representing current clinical practice. It maintains high negative predictive value while achieving higher positive predictive value, demonstrating its potential to safely reduce unnecessary biopsies during surveillance.
Biochemical recurrence (BCR) after radical prostatectomy is a critical endpoint in prostate cancer, yet risk stratification relies almost entirely on variables dominated by Gleason grade. Whether H&E whole slide images (WSIs) carry prognostic signal beyond grade, and whether multiple instance learning (MIL) can recover it, remains unsettled. A key obstacle is that many pipelines select model checkpoints on the evaluation fold, artificially inflating concordance. We construct a rigorous benchmark on TCGA-PRAD (487 patients, 101 BCR events) using strict out-of-fold scoring over five-fold cross-validation repeated across five seeds. The choice of MIL aggregator (ABMIL, CLAM, TransMIL, PatchGCN) has little effect (C-index 0.61-0.64 with UNI2-h), while the feature extractor is the dominant factor (ResNet50 0.566 versus pathology foundation models up to 0.639). A clinical Cox model on grade, stage, and age reaches 0.687; no imaging-only model significantly outperforms it (p > 0.10). We introduce Grade-Disentangled MIL (GD-MIL), a gated-attention MIL encoder trained with a gradient-reversal grade adversary that encourages the slide representation to be invariant to Gleason grade before late fusion with clinical variables. GD-MIL achieves C-index 0.704, significantly outperforming both the clinical baseline (delta-c = +0.029, p = 0.0005) and the best imaging-only model (delta-c = +0.062, p = 0.039), suggesting H&E morphology contains prognostic information complementary to grade. A median risk split yields log-rank p < 0.0001 separation in BCR-free survival (~20% vs ~70% at five years).
Immunohistochemistry (IHC)is frequently used to resolve diagnostically ambiguous prostate cancer biopsy findings on hematoxylin and eosin (H&E)-stained tissue. However, PIN-4 IHC staining is typically performed on adjacent tissue sections, limiting direct spatial comparison between the H&E morphology and the corresponding immunophenotypic signal. A paired, registered H&E/PIN-4 dataset was constructed from routine clinical prostate biopsy whole-slide images (WSIs), and a conditional generative adversarial network (cGAN) was trained to synthesize PIN-4 staining patterns directly from native H&E image patches. The final dataset comprised 172 paired WSIs from 93 patients and 27,298 registered 1024x1024 patch pairs, spanning adenocarcinoma-positive and benign cases with representation across age, race, and ethnicity groups. The model was evaluated on a held-out test set of 1,814 patch pairs from 17 WSIs, achieving a mean peak signal-to-noise ratio (PSNR) of 21.88 dB, structural similarity index measure (SSIM) of 0.667, Pearson correlation coefficient (PCC) of 0.684, and learned perceptual image patch similarity (LPIPS) of 0.417. Qualitative review by a board-certified pathologist showed that generated images captured diagnostically relevant PIN-4 staining patterns, including AMACR/racemase expression and basal-cell-associated staining, while preserving spatial correspondence with the source H&E morphology. Accuracy of synthesis varied across morphologically complex regions, including high-grade carcinoma and intraductal carcinoma. These results support the feasibility of supervised PIN-4 synthesis from routinely acquired brightfield H&E prostate biopsy images. The approach enables direct interpretation of predicted PIN-4 marker patterns in the context of the source prostate H&E architecture, addressing a current spatial limitation of conventional adjacent-section IHC.